MedTrace Logo

Early Dietary Treated Patients With Phenylketonuria Can Achieve Normal Growth and Mental Development.

NCT04302194 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-03-23

No results posted yet for this study

Summary

The study aim is to follow up body growth(body weight by kg, length by cm, head circumference, abdominal circumference, and body mass index ) and mental development of infants on phenylalanine restricted diet in comparison with normal matchable infants.

Conditions

  • Phenylketonurias

Interventions

DIETARY_SUPPLEMENT

phenylalanine restricted diet

Infants with hyperphenylalaninemia on special formula and diet

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Farouk Hassanein · Assiut University

Eligibility

Min Age
1 Month
Max Age
3 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2021-05-31
Completion
2021-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04302194 on ClinicalTrials.gov